resources

Jagsonpal Pharmaceuticals Ltd.

NSE: JAGSNPHARM

BSE: 507789

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

242.50-1.5 (-0.61%)

26 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Jagsonpal Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	Dec	Mar Sept	Mar Jun Sept Dec	Mar Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	29Jan 13May 31Jul 7Nov	27Jan 4May 4Aug
Presentations	—	—	—	—	—	—	—	—	—	21Feb	—	24Oct	6May 26Jul 3Nov	21Jan 27Apr 29Jul

Corporate Announcements and Regulatory Filings

Jagsonpal Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Allotment of ESOP / ESPS24 Aug 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee stock option Plan 2022
Newspaper Publication12 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement- 47th Annual General Meeting of the Company to be held on September 18, 2026
Analyst / Investor Meet30 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Jagsonpal Pharmaceuticals Limited Q1 FY27 Earnings Conference Call on July 30, 2026 at 2:30 P.M.
Newspaper Publication30 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026
Change in Management29 Jul 2026
Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management personnel of the Company
Record Date29 Jul 2026
Corporate Action- Record Date: September 04, 2026
Corporate Action- Record Date for dividend Purpose: September 04, 2026
Allotment of ESOP / ESPS29 Jul 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation for grant of Employee Stock Options
Press Release / Media Release29 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for Unaudited Financial results for quarter ended June 30, 2026
Outcome of Board Meeting29 Jul 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On July 29, 2026 Along With Unaudited (Standalone) Financial Results For The Quarter June 30, 2026
Outcome of Board Meeting held on July 29, 2026 along with Unaudited (Standalone) Financial Results for the quarter June 30, 2026
Analyst / Investor Meet22 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a ....
Board Meeting22 Jul 2026
Board Meeting Intimation for Prior Intimation Of Board Meeting
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the unaudited Financial ....
General17 Jul 2026
General-Updates
Updates on Acquisition of Aequitas Healthcare Private Limited.
Allotment of ESOP / ESPS15 Jul 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 94,000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022.
General8 Jul 2026
General-Updates
Updates on Acquisition of Aequitas Healthcare Private Limited
General7 Jul 2026
General Updates
Updates on Acquisition of Aequitas Healthcare Private Limited.
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018
Press Release / Media Release29 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on acquisition of Aequitas Healthcare Private Limited.
Acquisition29 Jun 2026
Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of Aequitas Healthcare Private Limited
Closure of Trading Window26 Jun 2026
Closure of Trading Window
Closure of Trading window for the quarter ended June 30, 2026
Press Release / Media Release25 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
press release relating to appointment of Mr. Anil Kumar Matai (DIN: 03122685) as an additional director in the category of Non-Executive Independent Director.

Frequently Asked Questions

Where can I download the annual report of Jagsonpal Pharmaceuticals Ltd.?

Annual reports of Jagsonpal Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Jagsonpal Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Jagsonpal Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Jagsonpal Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Jagsonpal Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Jagsonpal Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Jagsonpal Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Jagsonpal Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Jagsonpal Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Jagsonpal Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Jagsonpal Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Jagsonpal Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Jagsonpal Pharmaceuticals Ltd. is INE048B01035. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Jagsonpal Pharmaceuticals Ltd. listed?

Jagsonpal Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is JAGSNPHARM and the BSE code is -.

Where can I find the shareholding pattern of Jagsonpal Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Jagsonpal Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Jagsonpal Pharmaceuticals Ltd. on Sharpely?

Share price data for Jagsonpal Pharmaceuticals Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.